Literature DB >> 20433028

Partial characterization of normal and Haemophilus influenzae-infected mucosal complementary DNA libraries in chinchilla middle ear mucosa.

Joseph E Kerschner1, Geza Erdos, Fen Ze Hu, Amy Burrows, Joseph Cioffi, Pawjai Khampang, Margaret Dahlgren, Jay Hayes, Randy Keefe, Benjamin Janto, J Christopher Post, Garth D Ehrlich.   

Abstract

OBJECTIVES: We sought to construct and partially characterize complementary DNA (cDNA) libraries prepared from the middle ear mucosa (MEM) of chinchillas to better understand pathogenic aspects of infection and inflammation, particularly with respect to leukotriene biogenesis and response.
METHODS: Chinchilla MEM was harvested from controls and after middle ear inoculation with nontypeable Haemophilus influenzae. RNA was extracted to generate cDNA libraries. Randomly selected clones were subjected to sequence analysis to characterize the libraries and to provide DNA sequence for phylogenetic analyses. Reverse transcription-polymerase chain reaction of the RNA pools was used to generate cDNA sequences corresponding to genes associated with leukotriene biosynthesis and metabolism.
RESULTS: Sequence analysis of 921 randomly selected clones from the uninfected MEM cDNA library produced approximately 250,000 nucleotides of almost entirely novel sequence data. Searches of the GenBank database with the Basic Local Alignment Search Tool provided for identification of 515 unique genes expressed in the MEM and not previously described in chinchillas. In almost all cases, the chinchilla cDNA sequences displayed much greater homology to human or other primate genes than with rodent species. Genes associated with leukotriene metabolism were present in both normal and infected MEM.
CONCLUSIONS: Based on both phylogenetic comparisons and gene expression similarities with humans, chinchilla MEM appears to be an excellent model for the study of middle ear inflammation and infection. The higher degree of sequence similarity between chinchillas and humans compared to chinchillas and rodents was unexpected. The cDNA libraries from normal and infected chinchilla MEM will serve as useful molecular tools in the study of otitis media and should yield important information with respect to middle ear pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433028      PMCID: PMC2910914          DOI: 10.1177/000348941011900411

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  20 in total

Review 1.  Culture of middle ear epithelium: a review.

Authors:  A Nakamura; T Kumazawa; D J Lim; T F Demaria; C A van Blitterswijk
Journal:  Acta Otolaryngol Suppl       Date:  1993

2.  Characterization of the human cysteinyl leukotriene 2 receptor.

Authors:  C E Heise; B F O'Dowd; D J Figueroa; N Sawyer; T Nguyen; D S Im; R Stocco; J N Bellefeuille; M Abramovitz; R Cheng; D L Williams; Z Zeng; Q Liu; L Ma; M K Clements; N Coulombe; Y Liu; C P Austin; S R George; G P O'Neill; K M Metters; K R Lynch; J F Evans
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

3.  The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.

Authors:  J Takasaki; M Kamohara; M Matsumoto; T Saito; T Sugimoto; T Ohishi; H Ishii; T Ota; T Nishikawa; Y Kawai; Y Masuho; T Isogai; Y Suzuki; S Sugano; K Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2000-08-02       Impact factor: 3.575

4.  Variance of molecular datings, evolution of rodents and the phylogenetic affinities between Ctenodactylidae and Hystricognathi.

Authors:  D Huchon; F M Catzeflis; E J Douzery
Journal:  Proc Biol Sci       Date:  2000-02-22       Impact factor: 5.349

5.  Mucin gene cDNA sequence characterization in chinchilla middle ear epithelium.

Authors:  Joseph E Kerschner; Tanya K Meyer; Amy Burrows; Garth Ehrlich; J Christopher Post
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-05-02       Impact factor: 1.675

6.  Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.

Authors:  Claudina Angela Pérez-Novo; Jean Baptiste Watelet; Cindy Claeys; Paul Van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

7.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

Authors:  H M Sarau; R S Ames; J Chambers; C Ellis; N Elshourbagy; J J Foley; D B Schmidt; R M Muccitelli; O Jenkins; P R Murdock; N C Herrity; W Halsey; G Sathe; A I Muir; P Nuthulaganti; G M Dytko; P T Buckley; S Wilson; D J Bergsma; D W Hay
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

8.  Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans.

Authors:  Ioannis Moissidis; Birjis Chinoy; Krishna Yanamandra; Dawn Napper; Theodore Thurmon; Joseph Bocchini; Sami L Bahna
Journal:  Genet Med       Date:  2005 Jul-Aug       Impact factor: 8.822

9.  Implications of the AHRQ evidence report on acute otitis media.

Authors:  R M Rosenfeld; M L Casselbrant; M T Hannley
Journal:  Otolaryngol Head Neck Surg       Date:  2001-11       Impact factor: 3.497

10.  Cytokine regulation of mucin secretion in a human middle ear epithelial model.

Authors:  Erica A Samuel; Amy Burrows; Joseph E Kerschner
Journal:  Cytokine       Date:  2007-12-11       Impact factor: 3.861

View more
  2 in total

1.  Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin.

Authors:  Glen McGillivary; Zachary B Jordan; Mark E Peeples; Lauren O Bakaletz
Journal:  J Innate Immun       Date:  2012-09-25       Impact factor: 7.349

2.  Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Authors:  Teresa L Shaffer; Rachel Balder; Sean W Buskirk; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.